Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors

Sargsyan, A; Kucharczyk, MA; Jones, RL; Constantinidou, A

Constantinidou, A (通讯作者),Univ Cyprus, Med Sch, Palaios dromos Lefkosias Lemesou 215 6, CY-2029 Aglantzia, Nicosia, Cyprus.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023; 17 (2): 119

Abstract

IntroductionGastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Imatinib mesylate revolutionized......

Full Text Link